How to get cost-effectiveness analysis right? The case of vaccine economics in latin america.
Background: In middle-income countries, vaccines against pneumococcal disease, rotavirus, and human papilloma virus are in general more costly, not necessarily cost saving, and less consistently cost-effective than earlier generation vaccines against measles, diphtheria, tetanus, and pertussis. Budg...
- Autores:
- Tipo de recurso:
- Fecha de publicación:
- 2017
- Institución:
- Universidad de Bogotá Jorge Tadeo Lozano
- Repositorio:
- Expeditio: repositorio UTadeo
- Idioma:
- OAI Identifier:
- oai:expeditiorepositorio.utadeo.edu.co:20.500.12010/8943
- Acceso en línea:
- https://www.researchgate.net/publication/311656320_How_to_Get_Cost-Effectiveness_Analysis_Right_The_Case_of_Vaccine_Economics_in_Latin_America
http://hdl.handle.net/20.500.12010/8943
- Palabra clave:
- Cost-effectiveness
Developingcountries
Latin America
Vacunación -- Asectos económicos
Salud pública -- Aspectos económicos
- Rights
- License
- Abierto (Texto Completo)